High-Density Lipoprotein Cholesterol and the Risk of First Ischemic Stroke in a Chinese Hypertensive Population

Background and Purpose Elevated high-density lipoprotein cholesterol (HDL-C) levels have displayed protection against cardiovascular disease. However, the association between specific lipoprotein classes and first ischemic stroke (IS) has not been well defined, particularly in higher-risk hypertensive populations. Our study evaluated the associations of HDL-C with first IS in a Chinese hypertensive population. Methods The study population was obtained from a community-based cohort study of hypertension in Lianyungang and Rongcheng, China. A nested case-control design was used that included 2463 identified first IS cases and 2463 controls matched by age ± 1 year, sex, and region. Results After adjusting for potential confounders, HDL-C was inversely associated with first IS (adjusted odds ratio [aOR]: 0.91; 95% confidence interval [CI]: 0.85–0.98). HDL-C levels of at least 65.4 mg/dL displayed a significant protective effect for first IS (aOR: 0.82; 95% CI: 0.69–0.98). Conversely, adverse effects of first IS were observed for low-density lipoprotein cholesterol (LDL-C) levels ≥138.1 mg/dL (aOR: 1.20; 95% CI: 1.02–1.42) and triglyceride (TG) levels ≥140.8 mg/dL (aOR: 1.27; 95% CI: 1.09–1.49). The risk associations of LDL-C and TG with first IS were attenuated in the presence of high HDL-C (≥53.0 mg/dL); an increased risk of first IS was only found in the presence of low HDL-C (<53.0 mg/dL) when LDL-C (aOR: 1.66; 95% CI: 1.19–2.31) and TG (aOR: 1.47; 95% CI: 1.17–1.84) were combined with HDL-C for analysis. Conclusion In this community-based Chinese hypertensive population, higher HDL-C was a significant protective factor of first IS. These data add to the evidence describing the relationship between lipids and IS and suggest that HDL-C maybe is a marker of IS risk in Chinses hypertensive population.

[1]  Jun Lv,et al.  Causal associations of blood lipids with risk of ischemic stroke and intracerebral hemorrhage in Chinese adults , 2019, Nature Medicine.

[2]  A. Kengne,et al.  Validation of the Friedewald formula for the estimation of low density lipoprotein cholesterol in a sub-Saharan African population. , 2017, Clinical biochemistry.

[3]  Y. Kokubo,et al.  Association of high-density lipoprotein cholesterol concentration with different types of stroke and coronary heart disease: The Japan Public Health Center-based prospective (JPHC) study. , 2017, Atherosclerosis.

[4]  B. Nordestgaard Triglyceride-Rich Lipoproteins and Atherosclerotic Cardiovascular Disease: New Insights From Epidemiology, Genetics, and Biology. , 2016, Circulation research.

[5]  Anette Varbo,et al.  Triglycerides and cardiovascular disease , 2014, The Lancet.

[6]  Sarah Parish,et al.  Effects of extended-release niacin with laropiprant in high-risk patients. , 2014, The New England journal of medicine.

[7]  J. Willey,et al.  Cholesterol level and stroke: a complex relationship. , 2013, JAMA internal medicine.

[8]  Jiang He,et al.  Serum Lipids and Lipoproteins in Chinese Men and Women , 2012, Circulation.

[9]  M. Woodward,et al.  Isolated Low Levels of High-Density Lipoprotein Cholesterol Are Associated With an Increased Risk of Coronary Heart Disease: An Individual Participant Data Meta-Analysis of 23 Studies in the Asia-Pacific Region , 2011, Circulation.

[10]  R. Sacco,et al.  Lipid profile components and risk of ischemic stroke: the Northern Manhattan Study (NOMAS). , 2009, Archives of neurology.

[11]  J. Liao HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events. , 2008, Current atherosclerosis reports.

[12]  V. Feigin,et al.  Associations between high-density lipoprotein cholesterol and both stroke and coronary heart disease in the Asia Pacific region. , 2007, European heart journal.

[13]  P. Ridker,et al.  Lipid levels and the risk of ischemic stroke in women , 2007, Neurology.

[14]  A. Kontush,et al.  Small, Dense HDL Particles Exert Potent Protection of Atherogenic LDL Against Oxidative Stress , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[15]  K. Miura,et al.  High-Density Lipoprotein Cholesterol and Risk of Stroke in Japanese Men and Women: The Oyabe Study , 2003, Stroke.

[16]  L. Chambless,et al.  Plasma Lipid Profile and Incident Ischemic Stroke: The Atherosclerosis Risk in Communities (ARIC) Study , 2003, Stroke.

[17]  C. Ballantyne,et al.  Influence of Low High-Density Lipoprotein Cholesterol and Elevated Triglyceride on Coronary Heart Disease Events and Response to Simvastatin Therapy in 4S , 2001, Circulation.

[18]  S. Ebrahim,et al.  HDL-Cholesterol, total cholesterol, and the risk of stroke in middle-aged British men. , 2000, Stroke.

[19]  J. Gamble,et al.  Factors influencing the ability of HDL to inhibit expression of vascular cell adhesion molecule-1 in endothelial cells. , 1998, Arteriosclerosis, thrombosis, and vascular biology.

[20]  T. Fujinami,et al.  HDL3 exerts more powerful anti-oxidative, protective effects against copper-catalyzed LDL oxidation than HDL2. , 1997, Clinical biochemistry.

[21]  J. Hokanson,et al.  Plasma Triglyceride Level is a Risk Factor for Cardiovascular Disease Independent of High-Density Lipoprotein Cholesterol Level: A Metaanalysis of Population-Based Prospective Studies , 1996, Journal of cardiovascular risk.

[22]  Scandinavian Simvastatin Survival Study Group Baseline serum cholesterol and treatment effect in the Scandinavian Simvastatin Survival Study (4S) , 1995, The Lancet.

[23]  A. Tall An overview of reverse cholesterol transport. , 1994, European heart journal.

[24]  Vesa Manninen,et al.  Joint Effects of Serum Triglyceride and LDL Cholesterol and HDL Cholesterol Concentrations on Coronary Heart Disease Risk in the Helsinki Heart Study: Implications for Treatment , 1992, Circulation.

[25]  R B D'Agostino,et al.  Probability of stroke: a risk profile from the Framingham Study. , 1991, Stroke.

[26]  A. Gotto,et al.  Interrelationship of triglycerides with lipoproteins and high-density lipoproteins. , 1990, The American journal of cardiology.

[27]  P. P. Toth Niacin in Patients with Low HDL Cholesterol Levels Receiving Intensive Statin Therapy , 2012 .

[28]  G. Moneta,et al.  Major Lipids, Apolipoproteins, and Risk of Vascular Disease , 2010 .

[29]  J. Provencio High-Dose Atorvastatin after Stroke or Transient Ischemic Attack , 2007 .